EpiPose aims to provide urgently needed answers about the epidemiological characteristics of 2019-nCoV, the social dynamics of the outbreak, and the related public health preparedness and response to the ongoing pandemic, also assessing the economic impact of the pandemic.

Project details

EpiPose aims to deliver results quickly, according to the following objectives:

• To collect and share epidemiological data of 2019-nCoV as widely as possible;
• To provide country-specific estimates of key epidemiological parameters;
• To model the expected impact of 2019-nCoV on morbidity and mortality;
• To monitor awareness and behavioural change during the 2019-nCoV pandemic;
• To provide health economic analyses for interventions within the EU;
• To foster the interaction between the scientific community, public health agencies and the public EpiPose aims to make all research data, code, tools and results publicly available and its dissemination plan targets active communication and interaction with policymakers, other scientific groups and the general public.

As such, the epidemic intelligence provided by EpiPose will help minimise the 2019-nCoV’s public health, economic and social impact.

Consortium

The consortium consists of 6 partners in 5 countries (Belgium, Netherlands, United Kingdom, Zwitserland and Italy) who provide complementary expertise in mathematical and statistical modelling of infectious diseases, participatory surveillance systems, living systematic reviews, and health economic analysis and have a strong international public health network.

RIVM colleague involved: Jacco Wallinga. See also Modelling and Forecasting on EpiPose website for scientific output led by RIVM.

Funding

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101003688.